published in
- JAMA internal medicine Journal
Five-year downstream outcomes following prostate-specific antigen screening in older men.
- Overview
- Identity
- Additional Document Info
- View All
Overview
has subject area
- Age Factors
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- Biopsy
- Comorbidity
- Decision Making
- Early Detection of Cancer
- Erectile Dysfunction
- False Positive Reactions
- Humans
- Longitudinal Studies
- Male
- Mass Screening
- Medical Record Linkage
- Medicare
- Precision Medicine
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Risk Assessment
- Risk Factors
- Survival Analysis
- United States
- United States Department of Veterans Affairs
- Unnecessary Procedures
- Urinary Incontinence